- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Clene Inc. (CLNN)
Clene Inc. stock price live, this page displays NASDAQ CLNN stock exchange data. View the CLNN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Clene Inc. real time stock price chart below.
What Is the Clene Inc. Stock Price Today?
The Clene Inc. stock price today is 6.2600.
What Is the Stock Symbol for Clene Inc.?
The stock symbol for Clene Inc. is "CLNN."
What Stock Exchange Does Clene Inc. Trade On?
Clene Inc. is listed and trades on the NASDAQ stock exchange.
Is Clene Inc. a Good Stock to Buy?
Determining whether Clene Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLNN quote. (ISIN: US1856342019)
What Is the Clene Inc. Stock Price Today?
The Clene Inc. stock price today is 6.2600.
What Is the Stock Symbol for Clene Inc.?
The stock symbol for Clene Inc. is "CLNN."
What Stock Exchange Does Clene Inc. Trade On?
Clene Inc. is listed and trades on the NASDAQ stock exchange.
Is Clene Inc. a Good Stock to Buy?
Determining whether Clene Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLNN quote. (ISIN: US1856342019)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.0150
6.6574
52 wk Range
2.2801
13.5000
CLNN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.01506.6574
52 wk Range
2.280113.5000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CLNN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
31.8571
Upside
+408.90%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
- Clene receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Clene receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Clene receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Clene receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Clene Inc. For: 3 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Clene Inc. Company Profile
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain’s energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson’s Diseases. The company develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.
Compare CLNN to Peers and Sector
Metrics to compare | CLNN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCLNNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.1x | −3.4x | −0.6x | |
PEG Ratio | −0.05 | 0.00 | 0.00 | |
Price/Book | −5.2x | 3.2x | 2.6x | |
Price / LTM Sales | 302.3x | 274.4x | 3.2x | |
Upside (Analyst Target) | 379.2% | 75.7% | 41.8% | |
Fair Value Upside | Unlock | 0.0% | 5.1% | Unlock |
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 31.8571
(+408.90% Upside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.85 / -0.07
Revenue / Forecast
15.00K / --
People Also Watch
FAQ
What Is the Clene (CLNN) Stock Price Today?
The Clene stock price today is 6.2600
What Stock Exchange Does Clene Trade On?
Clene is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Clene?
The stock symbol for Clene is "CLNN."
What Is the Clene Market Cap?
As of today, Clene market cap is 64.69M.
What Is Clene's Earnings Per Share (TTM)?
The Clene EPS (TTM) is -3.29.
From a Technical Analysis Perspective, Is CLNN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Clene Stock Split?
Clene has split 1 times.
How Many Employees Does Clene Have?
Clene has 76 employees.
What is the current trading status of Clene (CLNN)?
As of Dec 24, 2025, Clene (CLNN) is trading at a price of 6.2600, with a previous close of 6.2600. The stock has fluctuated within a day range of 6.0150 to 6.6574, while its 52-week range spans from 2.2801 to 13.5000.
What Is Clene (CLNN) Price Target According to Analysts?
The average 12-month price target for Clene is USD31.85714, with a high estimate of USD48 and a low estimate of USD23. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +408.90% Upside potential.
What Is the CLNN After Hours Price?
CLNN's last after hours stock price is 6.0200, the stock has decreased by -0.2400, or -3.8300%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.